Reader Poll Results
Thanks for your response! We appreciate you taking the time to weigh in. Here's how other voters have responded thus far:
Results as of Friday, May 10, 2024, 10:43 CDT
This poll is not scientific and reflects the opinions of only those who have chosen to participate. Any sponsor of this poll is not responsible for the content or opinions expressed.
Related Story
Merck stops development of combination diabetes drug
Merck & Co. cited business reasons in its decision to stop development of a diabetes pill that would have combined its Januvia and a generic version of Lipitor, Pfizer's cholesterol drug. Drugmakers see combination drugs as a way to reduce the number of medications patients take. Merck already markets Juvisync, which is Januvia plus the cholesterol drug simvastatin.
TRI SmartBrief | Nov 28, 2012